EUVIMEDEUVIMED entdecken
Crossref

The Hidden Signal: Copper as an Underutilized Biomarker in Inflammation, Neurology, and Oncology

Riju Mathew, Sheena Joe

ICME JOURNAL OF LABORATORY MEDICINE · 2026 · 23-27

DOI: 10.54646/icme.2026.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ICME JOURNAL OF LABORATORY MEDICINE, 2026. Verfasst von Riju Mathew und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Copper (Cu) is an essential trace element with well-characterised roles in enzymatic catalysis, mitochondrial respiration, and redox regulation. Despite this, its potential as a clinical biomarker has received little attention in routine practice. Data from molecular biology, epidemiology, and translational research now position copper, and the copper-to-zinc (Cu/Zn) ratio, as measurable indicators of systemic inflammation, neurodegenerative progression, and malignant transformation. Scope: This review synthesises current evidence across three domains — inflammatory disease, neurological disorders, and oncology — to evaluate the diagnostic and prognostic utility of copper-related analytes. We examine the molecular mechanisms governing copper homeostasis, assess the clinical relevance of ceruloplasmin as an acute-phase reactant, and discuss the recently described phenomenon of cuproptosis as a target in cancer biology. Key Findings: Serum copper and ceruloplasmin rise significantly during systemic inflammation and correlate with disease severity across conditions from sepsis to autoimmune disorders. In neurodegenerative disease, copper dysregulation precedes clinical symptom onset in both Alzheimer's and Parkinson's diseases, suggesting a window for early biomarker use. In oncology, elevated serum copper has been documented across multiple tumour types; angiogenesis-promoting mechanisms have been linked to copper availability; and cuproptosis has introduced copper-targeted approaches to cancer therapy.

Zitieren

APA

Mathew, R., & Joe, S. (2026). The Hidden Signal: Copper as an Underutilized Biomarker in Inflammation, Neurology, and Oncology. ICME JOURNAL OF LABORATORY MEDICINE, 23-27. https://doi.org/10.54646/icme.2026.9

Vancouver

Mathew R, Joe S. The Hidden Signal: Copper as an Underutilized Biomarker in Inflammation, Neurology, and Oncology. ICME JOURNAL OF LABORATORY MEDICINE. 2026:23-27. doi:10.54646/icme.2026.9

BibTeX
@article{Mathew2026,
  author = {Mathew, Riju and Joe, Sheena},
  title = {The Hidden Signal: Copper as an Underutilized Biomarker in Inflammation, Neurology, and Oncology},
  journal = {ICME JOURNAL OF LABORATORY MEDICINE},
  year = {2026},
  pages = {23--27},
  doi = {10.54646/icme.2026.9}
}
Kostenlos starten →